Covid-19: UK will roll out Moderna’s omicron BA.1 vaccine as part of autumn booster programme

Moderna’s bivalent covid-19 vaccine—which targets both the original version of SARS-CoV-2 and the omicron BA.1 variant—will be rolled out alongside the original Moderna, Pfizer, and Novavax covid-19 vaccines, the Joint Committee on Vaccination and Immunisation (JCVI) has said.NHS England has yet to confirm how and when eligible people will be able to access the booster vaccine, but the UK Health Security Agency has said that it will be offered to those at higher risk of severe illness.Vaccines being rolled out in the autumn booster programmeThe JCVI has advised that adults aged 18 and over should be offered a single dose of one of the following:Moderna mRNA bivalent omicron BA.1/original “wild-type” vaccineModerna mRNA original “wild-type” vaccinePfizer-BioNTech mRNA (Comirnaty) original “wild-type” vaccineNovavax Matrix-M adjuvanted wild-type vaccine (Nuvaxovid)—which may be used when no alternative clinically suitable UK approved covid-19 vaccine is availableFor people aged 12 to 17:Pfizer-BioNTech mRNA (Comirnaty) original “wild-type” vaccineFor children…
Read Original Article: Covid-19: UK will roll out Moderna’s omicron BA.1 vaccine as part of autumn booster programme »